Nexira highlights new human evidence in women’s health and sports nutrition

Nexira will focus on four areas with proven human data: women’s health with BloomEase, winner of the NIE Awards 2026, addressing PMS; sports nutrition with ViNitrox for performance; fibre and longevity

Women’s health: BloomEase™ bridges an unmet need in PMS

Premenstrual syndrome remains one of the most common yet underserved needs in women’s health. Nexira will introduce BloomEase™, a new ingredient designed to support women before and during menstruation. It combines Achillea millefolium (white yarrow) flower extract with marine-sourced magnesium to address both physical and mood-related symptoms.

Nexira highlights new human evidence in women’s health and sports nutrition

In a placebo-controlled real-life study conducted in 167 women, BloomEase™ (520 mg once daily) demonstrated a significantly faster and greater reduction in menstrual discomfort versus placebo, along with improved quality of life and reduced PMS severity across cycles.

BloomEase™ is the winner of the NIE Awards 2026 in the Condition Specific category.

Sports nutrition: ViNitrox™. Push harder. Last longer. Recover faster.

ViNitrox™ is a combination of apple and grape polyphenols designed to help performance-driven athletes get more from every workout, naturally and without stimulants. With new human clinical evidence, its performance story is now stronger than ever.

What can athletes really expect from a sports nutrition ingredient?

To sustain performance. Delay fatigue. And support recovery.

That’s exactly where ViNitrox™ delivers. A comprehensive scientific package, spanning mechanistic research and human clinical studies, shows that ViNitrox™ can help athletes:

  • Increase time to exhaustion by 9.7%
  • Delay maximal perceived exertion by 12.8%
  • Support recovery-related physiological processes

And now, new human clinical evidence takes science further.

A new randomised, double-blind, placebo-controlled crossover clinical study in physically active adults demonstrates that ViNitrox™:

  • Improves flow-mediated dilation (FMD) by 41% versus placebo, supporting enhanced vascular responsiveness
  • Increases FeNO, a marker associated with nitric oxide blood circulation
  • Significantly reduces heart rate at rest and during exercise, for a more efficient cardiovascular response to exercise

Beyond performance, previous research also demonstrated a 48% reduction in inflammatory response following an acute challenge, further supporting recovery-related physiological processes.

Nexira highlights new human evidence in women’s health and sports nutrition

With a low and formulation-friendly 500 mg dose, a stimulant-free positioning and more than 10 years on the market, ViNitrox™ combines proven performance with a new generation of clinical science designed for sports nutrition.

Acacia fibre: 30 years of Fibregum™, still leading

2026 marks the 30th anniversary of Fibregum™, a milestone reflecting customer trust and more than 40 years of Nexira research on acacia fibre. Nexira will highlight its complete range, including Fibregum™ and inavea™, designed to support digestive comfort for GLP-1 users, enable fibre enrichment in nutrient-dense formulations and deliver prebiotic effects.

Thanks to its slow and progressive fermentation, acacia fibre offers high digestive tolerance. At 10 g/day, it significantly increased Bifidobacterium and, in 120 subjects with IBS-C, significantly increased bowel movements by 1.3 per week.

Clinical study, n=20 (Cherbut et al., 2003).

Clinical study, n=20 (Cherbut et al., 2003).

Inavea™ is a finalist of the NIE Awards 2026 in the Biotics category.

Longevity: targeting cellular health and microbiome

Nexira is also entering the fast-growing longevity segment with a dedicated collection. NU4LIFE™ is a new ingredient designed to support cellular regeneration and mitochondrial function, two key pillars of healthy ageing. It is complemented by VinOgrape™ Plus, a grape polyphenol extract with demonstrated prebiotic activity, shown to modulate the gut microbiome and increase beneficial bacteria such as Akkermansia muciniphila, associated with metabolic health and age-related dysbiosis.

Visit our website for more information. 

You may also like